Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the ‘DIAVE’ mobilizing regimen

[1]  A. Maseri.  Inflammation in acute coronary syndromes. , 2001, Haematologica.

[2]  A. Balduzzi,et al.  Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions , 2001, Leukemia.

[3]  G. Dini,et al.  Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. , 2000, Haematologica.

[4]  L. Madero,et al.  Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review , 2000, Bone Marrow Transplantation.

[5]  S. Koscielny,et al.  Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice , 2000, Bone Marrow Transplantation.

[6]  M. Kletzel,et al.  Analysis of parameters affecting engraftment in children undergoing autologous peripheral blood stem cell transplants , 2000, Bone Marrow Transplantation.

[7]  J. Luider,et al.  Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens , 1999, Bone Marrow Transplantation.

[8]  P. Marson,et al.  Peripheral blood stem cell collection and transplantation in paediatric malignancies: a monocentric experience. , 1998, Bone marrow transplantation.

[9]  I. Badell,et al.  Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission , 1998, Bone Marrow Transplantation.

[10]  J. Chessels.  RELAPSED LYMPHOBLASTIC LEUKAEMIA IN CHILDREN: A CONTINUING CHALLENGE , 1998 .

[11]  T. Witte,et al.  Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission , 1998, Bone Marrow Transplantation.

[12]  Keith Wheatley,et al.  Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial , 1998, The Lancet.

[13]  S. Sallan,et al.  Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. , 1997, Blood.

[14]  P. Perseghin,et al.  Satisfactory recovery and viability of stem cells cryopreserved at high cell concentration. , 1997, Transfusion Science.

[15]  L. To,et al.  The biology and clinical uses of blood stem cells. , 1997, Blood.

[16]  G. Demetri,et al.  Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte‐colony‐stimulating factor: implications for yield of hematopoietic progenitor cell collections , 1996, Transfusion.

[17]  G. Henze,et al.  Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis , 1995, The Lancet.

[18]  Y. Kawano,et al.  Collection and transplantation of peripheral blood stem cells in very small children weighting 20 kg or less. , 1995, Blood.

[19]  J. Nemunaitis,et al.  Cyclophosphamide-mobilized peripheral blood stem cells in patient with lymphoid malignancies. , 1995, Bone marrow transplantation.

[20]  T. Gooley,et al.  Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. , 1994, Blood.

[21]  N. Gorin.  Collection, manipulation and freezing of haemopoietic stem cells. , 1986, Clinics in haematology.